The Asia Pacific coronary stent market is expected to attain a market size of $3.5 billion by 2022 growing at a CAGR of 9.5 % during the forecast period (2016 - 2022).
The China region would continue its dominance and would attain a market size of $1.7 billion by 2022. The Drug Eluting Stents segment is expected to further grow at a CAGR of 8.6% during the forecast period thereby maintaining its dominance in the Asia Pacific market. However, the Bioresorable Vascular Scaffold segment would grow at the highest CAGR.
Introducing innovative products, and exploring new markets are the major strategies of the leading players. In July 2016, Abbott Vascular launched its first biodegradable stent called Absorb GT1 BVS. The product launched was to increase the market share in the vertical and help Abbott to be the leader in the coronary stent market.
Asia Pacific due to its market landscape and changing eco system would be the fastest growing region. Factors such as ease of doing business, sizable population, fast growing economic development, and swift adoption of latest technologies have contributed to the growth of the market in the region.
The report aims at providing stakeholders with an in-depth analysis of the North America Coronary stents market. The current & future market trends of the technology are pinpointed in a highly strategic manner. With the report in hand, investors can gain highly strategic market insights to base their discretion for investments. Market estimation of the current market and estimations through 2016-2022 would provide the complete financial potency of the market.
Key Topics Covered:
1. Market Scope & Methodology
1.1 Market Definition
1.3 Market Scope
1.5 Research Methodology
2. Executive Summary
3. Asia Pacific Coronary Stents Market Overview
3.2 Asia Pacific Coronary Stents Market
4. Asia Pacific Coronary Stent Market, By Product Type
5. Asia Pacific Drug Eluting Stents Market - By Type
6. Asia Pacific Coronary Stents Market - By Country
7. Company Profiles
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc.
- Terumo Corporation
- Braun Melsungen AG
- Stentys SA
- MicroPort Scientific Corporation
- C. R. Bard, INC
For more information about this report visit http://www.researchandmarkets.com/research/594xjs/asia_pacific